Response

Lorraine Pelosof^{1

2}, Chul Ahn³, Joan Schiller^{1

4}

Affiliations

¹ Department of Internal Medicine, Hematology/Oncology, Harold C. Simmons Comprehensive Cancer Center.
² Division of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
³ Department of Biostatistics and The University of Texas Southwestern Medical Center, Dallas, TX.
⁴ Inova Schar Cancer Institute, Fairfax, VA.

Comment

Lorraine Pelosof et al. J Natl Cancer Inst. 2018.

. 2018 Apr 1;110(4):435.

doi: 10.1093/jnci/djx217.

Lorraine Pelosof^{1

2}, Chul Ahn³, Joan Schiller^{1

4}

¹ Department of Internal Medicine, Hematology/Oncology, Harold C. Simmons Comprehensive Cancer Center.
² Division of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
³ Department of Biostatistics and The University of Texas Southwestern Medical Center, Dallas, TX.
⁴ Inova Schar Cancer Institute, Fairfax, VA.

No abstract available

Comment on

Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.
Pelosof L, Ahn C, Gao A, Horn L, Madrigales A, Cox J, McGavic D, Minna JD, Gazdar AF, Schiller J. Pelosof L, et al. J Natl Cancer Inst. 2017 Jan 28;109(7):djw295. doi: 10.1093/jnci/djw295. Print 2017 Jan. J Natl Cancer Inst. 2017. PMID: 28132018 Free PMC article.
RE: Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.
Page BJ, Bowman RV, Yang IA, Fong KM. Page BJ, et al. J Natl Cancer Inst. 2018 Apr 1;110(4):432. doi: 10.1093/jnci/djx216. J Natl Cancer Inst. 2018. PMID: 29045674 No abstract available.